PYXIS ONCOLOGY INC (PYXS) Institutional Shareholders
PYXIS ONCOLOGY INC (PYXS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $101.10M in PYXS holdings during the latest filing period.
Gordonmd Global Investments Lp is currently the largest disclosed institutional shareholder of PYXS tracked by InsiderSet, reporting ownership valued at approximately $30.17M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $33.48M, representing an estimated gain of +10.96% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 84% of the total disclosed PYXS value among the investors covered in this analysis. Major shareholders include Gordonmd Global Investments Lp, Pfizer Inc, Laurion Capital Management Lp, and several other long-term asset managers with concentrated positions in PYXIS ONCOLOGY INC (PYXS).
This page ranks the largest institutional PYXS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
77
Total Reported Value
$101.10M
Largest Holder
Gordonmd Global Investments Lp
Largest Position
$30.17M
Insider Transactions (90d)
1
Latest Filing Quarter
Q2 2026
New Institutional Positions
100
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Gordonmd Global Investments Lp | 14.60% | 10,024,909 | $30,174,976 | $33,483,196 | +$3,308,220 | +10.96% | |
| Pfizer Inc | 11.43% | 7,032,770 | $19,480,773 | $23,489,452 | +$4,008,679 | +20.58% | |
| Laurion Capital Management Lp | 1.07% | 4,900,888 | $14,751,673 | $16,368,966 | +$1,617,293 | +10.96% | |
| Vanguard Capital Management Llc | 0.00% | 2,075,997 | $6,248,751 | $6,933,830 | +$685,079 | +10.96% | |
| Atle Fund Management Ab | 0.78% | 966,459 | $2,909,041 | $3,227,973 | +$318,932 | +10.96% | |
| Blackrock, Inc. | 0.00% | 867,934 | $2,612,481 | $2,898,900 | +$286,419 | +10.96% | |
| Palo Alto Investors Lp | 0.36% | 864,277 | $2,601,474 | $2,886,685 | +$285,211 | +10.96% | |
| Marshall Wace, Llp | 0.00% | 830,544 | $2,499,936 | $2,774,017 | +$274,081 | +10.96% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 772,232 | $2,324,418 | $2,579,255 | +$254,837 | +10.96% |
| Geode Capital Management, Llc | 0.00% | 591,849 | $1,782,698 | $1,976,776 | +$194,078 | +10.89% | |
| Woodline Partners Lp | 0.00% | 523,999 | $1,577,237 | $1,750,157 | +$172,920 | +10.96% | |
| 683 Capital Management, Llc | 0.13% | 459,367 | $1,382,695 | $1,534,286 | +$151,591 | +10.96% | |
| Jacobs Levy Equity Management, Inc | 0.00% | 428,606 | $1,290,104 | $1,431,544 | +$141,440 | +10.96% | |
| Longaeva Partners L.P. | 0.03% | 353,582 | $1,064,282 | $1,180,964 | +$116,682 | +10.96% | |
| Decheng Capital Llc | 0.13% | 326,810 | $983,698 | $1,091,545 | +$107,847 | +10.96% | |
| Vanguard Fiduciary Trust Co | 0.00% | 302,986 | $911,988 | $1,011,973 | +$99,985 | +10.96% | |
| Jane Street Group, Llc | 0.00% | 290,090 | $873,171 | $968,901 | +$95,730 | +10.96% | |
| State Street Corp | 0.00% | 248,837 | $748,999 | $831,116 | +$82,117 | +10.96% | |
| Millennium Management Llc | 0.00% | 233,004 | $701,342 | $778,233 | +$76,891 | +10.96% | |
| Ubs Group Ag | 0.00% | 155,217 | $467,203 | $518,425 | +$51,222 | +10.96% | |
| Bank Of New York Mellon Corp | 0.00% | 133,996 | $403,328 | $447,547 | +$44,219 | +10.96% | |
| Acadian Asset Management Llc | 0.00% | 126,793 | $380,000 | $423,489 | +$43,489 | +11.44% | |
| Northern Trust Corp | 0.00% | 123,959 | $373,117 | $414,023 | +$40,906 | +10.96% | |
| Newedge Wealth, Llc | 0.00% | 116,006 | $349,178 | $387,460 | +$38,282 | +10.96% | |
| Xtx Topco Ltd | 0.00% | 110,939 | $333,926 | $370,536 | +$36,610 | +10.96% | |
| Two Sigma Investments, Lp | 0.00% | 83,961 | $252,723 | $280,430 | +$27,707 | +10.96% | |
| Bridgeway Capital Management, Llc | 0.00% | 81,260 | $244,593 | $271,408 | +$26,815 | +10.96% | |
| Bank Of America Corp | 0.00% | 80,464 | $242,197 | $268,750 | +$26,553 | +10.96% | |
| Stifel Financial Corp | 0.00% | 70,437 | $212,015 | $235,260 | +$23,245 | +10.96% | |
| Cable Car Capital, Lp | 0.00% | 61,606 | $185,434 | $205,764 | +$20,330 | +10.96% | |
| Myda Advisors Llc | 0.04% | 50,000 | $150,500 | $167,000 | +$16,500 | +10.96% | |
| Qube Research & Technologies Ltd | 0.00% | 49,932 | $150,295 | $166,773 | +$16,478 | +10.96% | |
| University Of Chicago | 0.03% | 48,731 | $146,680 | $162,762 | +$16,082 | +10.96% | |
| Citadel Advisors Llc | 0.00% | 47,317 | $142,424 | $158,039 | +$15,615 | +10.96% | |
| Quadrature Capital Ltd | 0.00% | 47,067 | $141,672 | $157,204 | +$15,532 | +10.96% | |
| Goldman Sachs Group Inc | 0.00% | 45,900 | $138,159 | $153,306 | +$15,147 | +10.96% | |
| Verdad Advisers, Lp | 0.13% | 44,899 | $135,146 | $149,963 | +$14,817 | +10.96% | |
| Lpl Financial Llc | 0.00% | 43,554 | $131,098 | $145,470 | +$14,372 | +10.96% | |
| Commonwealth Equity Services, Llc | 0.00% | 42,455 | $127,790 | $141,800 | +$14,010 | +10.96% | |
| J. Derek Lewis & Associates Inc. | 0.02% | 42,000 | $126,420 | $140,280 | +$13,860 | +10.96% | |
| Citigroup Inc | 0.00% | 38,205 | $114,997 | $127,605 | +$12,608 | +10.96% | |
| Simplex Trading, Llc | 0.00% | 37,902 | $114,085 | $126,593 | +$12,508 | +10.96% | |
| Point72 Asset Management, L.P. | 0.00% | 37,092 | $111,647 | $123,887 | +$12,240 | +10.96% | |
| Walleye Capital Llc | 0.00% | 36,778 | $110,702 | $122,839 | +$12,137 | +10.96% | |
| Dimensional Fund Advisors Lp | 0.00% | 36,175 | $108,887 | $120,825 | +$11,938 | +10.96% | |
| Morgan Stanley | 0.00% | 33,448 | $100,679 | $111,716 | +$11,037 | +10.96% | |
| Mackenzie Financial Corp | 0.00% | 26,343 | $79,292 | $87,986 | +$8,694 | +10.96% | |
| Cetera Investment Advisers | 0.00% | 25,000 | $75,250 | $83,500 | +$8,250 | +10.96% | |
| Graham Capital Management, L.P. | 0.00% | 22,708 | $68,351 | $75,845 | +$7,494 | +10.96% | |
| Vanguard Global Advisers, Llc | 0.00% | 21,242 | $63,938 | $70,948 | +$7,010 | +10.96% |
Frequently asked questions about PYXS
Who owns the most PYXS stock?
The largest holders of PYXS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for PYXIS ONCOLOGY INC (PYXS).
Is PYXS widely held by superinvestors?
Many widely followed stocks like PYXS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly PYXS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.